Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Feasibility and Acceptability of a Positive Psychological Intervention for Patients With Type 2 Diabetes.

DuBois CM, Millstein RA, Celano CM, Wexler DJ, Huffman JC.

Prim Care Companion CNS Disord. 2016 May 5;18(3). doi: 10.4088/PCC.15m01902. eCollection 2016.

2.

Erratum to: Increased microenvironment stiffness in damaged myofibers promotes myogenic progenitor cell proliferation.

Trensz F, Lucien F, Couture V, Söllrald T, Drouin G, Rouleau AJ, Dubois CM, Grandbois M, Lacraz G, Grenier G.

Skelet Muscle. 2015 Sep 17;5:31. doi: 10.1186/s13395-015-0053-7. eCollection 2015.

3.

High Glucose Up-regulates ADAM17 through HIF-1α in Mesangial Cells.

Li R, Uttarwar L, Gao B, Charbonneau M, Shi Y, Chan JS, Dubois CM, Krepinsky JC.

J Biol Chem. 2015 Aug 28;290(35):21603-14. doi: 10.1074/jbc.M115.651604. Epub 2015 Jul 14.

4.

Positive Psychological Interventions for Patients with Type 2 Diabetes: Rationale, Theoretical Model, and Intervention Development.

Huffman JC, DuBois CM, Millstein RA, Celano CM, Wexler D.

J Diabetes Res. 2015;2015:428349. doi: 10.1155/2015/428349. Epub 2015 Apr 29. Review.

5.

Relationships between positive psychological constructs and health outcomes in patients with cardiovascular disease: A systematic review.

DuBois CM, Lopez OV, Beale EE, Healy BC, Boehm JK, Huffman JC.

Int J Cardiol. 2015 Sep 15;195:265-80. doi: 10.1016/j.ijcard.2015.05.121. Epub 2015 May 21. Review.

6.

An exploratory mixed methods analysis of adherence predictors following acute coronary syndrome.

Huffman JC, Moore SV, DuBois CM, Mastromauro CA, Suarez L, Park ER.

Psychol Health Med. 2015;20(5):541-50. doi: 10.1080/13548506.2014.989531. Epub 2014 Dec 15.

7.

Vascular induction of a disintegrin and metalloprotease 17 by angiotensin II through hypoxia inducible factor 1α.

Obama T, Takayanagi T, Kobayashi T, Bourne AM, Elliott KJ, Charbonneau M, Dubois CM, Eguchi S.

Am J Hypertens. 2015 Jan;28(1):10-4. doi: 10.1093/ajh/hpu094. Epub 2014 May 28.

8.

Simultaneous pH measurement in endocytic and cytosolic compartments in living cells using confocal microscopy.

Lucien F, Harper K, Pelletier PP, Volkov L, Dubois CM.

J Vis Exp. 2014 Apr 28;(86). doi: 10.3791/51395.

9.

HDAC6 deacetylase activity is required for hypoxia-induced invadopodia formation and cell invasion.

Arsenault D, Brochu-Gaudreau K, Charbonneau M, Dubois CM.

PLoS One. 2013;8(2):e55529. doi: 10.1371/journal.pone.0055529. Epub 2013 Feb 6.

10.

Transglutaminase 2 cross-linking activity is linked to invadopodia formation and cartilage breakdown in arthritis.

Lauzier A, Charbonneau M, Paquette M, Harper K, Dubois CM.

Arthritis Res Ther. 2012 Jul 4;14(4):R159. doi: 10.1186/ar3899.

11.

Hypoxia-induced invadopodia formation involves activation of NHE-1 by the p90 ribosomal S6 kinase (p90RSK).

Lucien F, Brochu-Gaudreau K, Arsenault D, Harper K, Dubois CM.

PLoS One. 2011;6(12):e28851. doi: 10.1371/journal.pone.0028851. Epub 2011 Dec 27.

12.

Variation in levels of luteinizing hormone and reproductive photoresponsiveness in a population of white-footed mice (Peromyscus leucopus).

Heideman PD, Pittman JT, Schubert KA, Dubois CM, Bowles J, Lowe SM, Price MR.

Am J Physiol Regul Integr Comp Physiol. 2010 Jun;298(6):R1543-8. doi: 10.1152/ajpregu.00686.2009. Epub 2010 Mar 31.

13.

Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme.

Dubois CM, Blanchette F, Laprise MH, Leduc R, Grondin F, Seidah NG.

Am J Pathol. 2001 Jan;158(1):305-16.

14.

TGFbeta1 regulates gene expression of its own converting enzyme furin.

Blanchette F, Day R, Dong W, Laprise MH, Dubois CM.

J Clin Invest. 1997 Apr 15;99(8):1974-83.

15.

Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors.

Rusten LS, Smeland EB, Jacobsen FW, Lien E, Lesslauer W, Loetscher H, Dubois CM, Jacobsen SE.

J Clin Invest. 1994 Jul;94(1):165-72.

17.

Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action.

Dubois CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppenheim JJ, Keller JR.

J Exp Med. 1990 Sep 1;172(3):737-44.

Supplemental Content

Loading ...
Support Center